相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
Phoebe K. Mondala et al.
CELL STEM CELL (2021)
Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer
Nalee Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2α
Keywan Mortezaee
LIFE SCIENCES (2020)
Organoid and Assembloid Technologies for Investigating Cellular Crosstalk in Human Brain Development and Disease
Rebecca M. Marton et al.
TRENDS IN CELL BIOLOGY (2020)
Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications
Dinh-Toi Chu et al.
CELLS (2020)
Just eat it: A review of CD47 and SIRP-alpha antagonism
Bryan Oronsky et al.
SEMINARS IN ONCOLOGY (2020)
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
Agnieszka Gabka-Buszek et al.
VACCINES (2020)
Role of CD47 in Hematological Malignancies
Entsar Eladl et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2
Muhammad Mushtaq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Molecular imaging and deep learning analysis of uMUC1 expression in response to chemotherapy in an orthotopic model of ovarian cancer
Hongwei Zhao et al.
SCIENTIFIC REPORTS (2020)
Creation of bladder assembloids mimicking tissue regeneration and cancer
Eunjee Kim et al.
NATURE (2020)
The Effects of a Varied Gold Shell Thickness on Iron Oxide Nanoparticle Cores in Magnetic Manipulation, T1 and T2 MRI Contrasting, and Magnetic Hyperthermia
Grace Brennan et al.
NANOMATERIALS (2020)
Aminodextran Coated CoFe2O4 Nanoparticles for Combined Magnetic Resonance Imaging and Hyperthermia
Sumera Khizar et al.
NANOMATERIALS (2020)
Lissajous scanning magnetic particle imaging as a multifunctional platform for magnetic hyperthermia therapy
James Wells et al.
NANOSCALE (2020)
Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy
Dandan Liu et al.
THERANOSTICS (2020)
CD133: beyond a cancer stem cell biomarker
Amir Barzegar Behrooz et al.
JOURNAL OF DRUG TARGETING (2019)
uMUC1-Targeting Magnetic Resonance Imaging of Therapeutic Response in an Orthotropic Mouse Model of Colon Cancer
Hongwei Zhao et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
Said M. Afify et al.
CANCERS (2019)
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
Lu Wang et al.
MOLECULAR CANCER (2019)
Mechanisms, Hallmarks, and Implications of Stem Cell Quiescence
Inchul J. Cho et al.
STEM CELL REPORTS (2019)
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy
Masoud Najafi et al.
LIFE SCIENCES (2019)
CD133 in Breast Cancer Cells: More than a Stem Cell Marker
Federica Brugnoli et al.
JOURNAL OF ONCOLOGY (2019)
CD47 promotes cell growth and motility in epithelial ovarian cancer
Chiu-Lin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
Song-pei Li et al.
ACTA PHARMACOLOGICA SINICA (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
Nigel G. Kooreman et al.
CELL STEM CELL (2018)
Two States of Myeloma Stem Cells
Shmuel Yaccoby
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting
Buddhadev Layek et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma
Iris Rabinovich et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2018)
Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis
Jiasheng Xu et al.
STEM CELLS INTERNATIONAL (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies
Ping Wang et al.
STEM CELLS INTERNATIONAL (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Stem cells in cancer therapy: opportunities and challenges
Cheng-Liang Zhang et al.
ONCOTARGET (2017)
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
Pedro M. Aponte et al.
STEM CELLS INTERNATIONAL (2017)
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
Anwarul Hasan et al.
FRONTIERS IN NEUROLOGY (2017)
Recent advances in radiation oncology
Cristina Garibaldi et al.
ECANCERMEDICALSCIENCE (2017)
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo et al.
BRITISH JOURNAL OF CANCER (2016)
Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer
Ping Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
Nazanin Hoshyar et al.
NANOMEDICINE (2016)
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
Peyman Ranji et al.
TUMOR BIOLOGY (2016)
A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
Sukhbir Kaur et al.
ONCOTARGET (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Ranjeeta Thapa et al.
STEM CELLS INTERNATIONAL (2016)
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
Wanyin Chen et al.
STEM CELLS INTERNATIONAL (2016)
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Michele Cioffi et al.
CLINICAL CANCER RESEARCH (2015)
Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems
Faranak Salman Nouri et al.
JOURNAL OF CONTROLLED RELEASE (2015)
CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
Kazumichi Yoshida et al.
CANCER MEDICINE (2015)
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
A. Borah et al.
ONCOGENESIS (2015)
The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds
Anne M. Hocking
ADVANCES IN WOUND CARE (2015)
Therapeutic Targeting of Cancers with Loss of PTEN Function
Lloye M. Dillon et al.
CURRENT DRUG TARGETS (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin
Barbara S. Mallon et al.
STEM CELL RESEARCH (2014)
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance
Patricia E. de Almeida et al.
NATURE COMMUNICATIONS (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
Shoichiro Takeishi et al.
CANCER CELL (2013)
FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Brett G. Hollier et al.
CANCER RESEARCH (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular regulation of stem cell quiescence
Tom H. Cheung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
In Situ Tissue Regeneration: Chemoattractants for Endogenous Stem Cell Recruitment
Wendy S. Vanden Berg-Foels
TISSUE ENGINEERING PART B-REVIEWS (2013)
Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
Ning Ning et al.
CANCER RESEARCH (2012)
Molecular Imaging of Stem Cell Transplantation for Neurodegenerative Diseases
Ping Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Rat Multipotent Mesenchymal Stromal Cells Lack Long-Distance Tropism to 3 Different Rat Glioma Models
Daniel Bexell et al.
NEUROSURGERY (2012)
Vaccination with Embryonic Stem Cells Protects against Lung Cancer: Is a Broad-Spectrum Prophylactic Vaccine against Cancer Possible?
Kavitha Yaddanapudi et al.
PLOS ONE (2012)
Dissecting the Oncogenic and Tumorigenic Potential of Differentiated Human Induced Pluripotent Stem Cells and Human Embryonic Stem Cells
Zhumur Ghosh et al.
CANCER RESEARCH (2011)
Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche
Cristina Grange et al.
CANCER RESEARCH (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Adhesion molecules Key players in Mesenchymal stem cell-mediated immunosuppression
Guangwen Ren et al.
CELL ADHESION & MIGRATION (2011)
Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
Hao Cheng et al.
ACS NANO (2010)
Recent Advances in Cancer Therapy: An Overview
A. Urruticoechea et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine
S. P. Medvedev et al.
ACTA NATURAE (2010)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Embryonic vaccines against cancer: An early history
Bradley G. Brewer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Introduction to Stem Cell Therapy
Jesse K. Biehl et al.
JOURNAL OF CARDIOVASCULAR NURSING (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
An overview of cancer multidrug resistance: a still unsolved problem
H. Lage
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors
Sergey V. Shmelkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Re-setting the biologic rationale for thermal therapy
MW Dewhirst et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
How is the immune response affected by hyperthermia and heat shock proteins?
SK Calderwood et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia
M Olsson et al.
BLOOD (2005)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
Docetaxel for treatment of solid tumours: a systematic review of clinical data
A Montero et al.
LANCET ONCOLOGY (2005)
From latent disseminated cells to overt metastasis:: Genetic analysis of systemic breast cancer progression
O Schmidt-Kittler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma
JD Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells
BR Blazar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Integrin-associated protein (CD47) and its ligands
EJ Brown et al.
TRENDS IN CELL BIOLOGY (2001)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
